IGF1 LR3 from Nanox is a modified molecule of an insulin-like growth factor of the feather type, structurally representing a protein similar to an insulin molecule that has some insulin-like effects (in particular, acceleration of glucose utilization), at the same time, insulin itself is able to activate IGF-1 receptors, but 200 times worse than IGF itself.
IGF1 LR3 is a powerful anabolic agent that provides the growth of lean muscle mass, regeneration of any injuries and wounds, improvement of fat burning, normalization of internal organs and glands, improvement of the immune system and acceleration of recovery after physical overload.
Mechanism of action
IGF-1 LR3 belongs to a class of peptide compounds that are vital for the development of any mammalian organism. IGF1-LR3 differs from the natural peptide hormone in that the arginine molecule is replaced by glutamic acid in the third position in the amino acid structure sequence, at the same time 13 more amino acids are added to the molecule at the N-end, resulting in 83 amino acids instead of 70 in the endogenous peptide hormone.
Thus, IGF-1 LR3 has an anabolic effect of the initial peptide as an activator of the IGF-1 receptor, while it binds very poorly to insulin-like proteins (that is, it is constantly in free active form), improving metabolic stability. As a result, it is about three times more effective than conventional IGF-1, and its half-life is 20-30 hours (in IGF-1 it is 12-15 hours). IGF-1 LR3 mediates most of the work of growth hormone, that is, IGF-1 is produced in response to the introduction of growth hormone in the liver, and then affects specific receptors activating cell growth and other effects.
One such example is muscle growth and hyperplasia. And if the mechanical growth factor (MGF) contributes to an increase in the number of satellite cells, then it is IGF-1 that promotes the transformation of these cells into myocytes and further into new muscle cells, in fact leading to an increase in the number of muscle fibers.
It should be clarified that neither growth hormone nor IGF1 LR3 are the cause of the development of cancerous tumors, however, if they are present (undiagnosed malignant or benign formations), these peptide compounds can accelerate their development, since they activate the growth of all cells of the body. Therefore, it is advisable for an athlete to undergo a full diagnosis to identify possible tumors. Before us is an effective tool for the growth of muscle fibers and the burning of adipose tissue.
Subcutaneous injection of IGF1 LR3 with an insulin syringe into the fold of the skin of the abdomen 1 time a day at a dose of 100 mcg, the course duration is 4-5 weeks.
The peptide is supplied in powder form, so it needs to be restored with bacteriostatic water, water is injected with a conventional syringe for intramuscular injections through a rubber cap (it does not need to be removed from the vial), while water should flow down the wall of the vial, and not directly into the drug (to avoid destruction of the structure of the peptide). After that, wait until the drug dissolves itself (it should not be shaken or shaken, as this will damage its structure). The drug should be stored in the refrigerator at a temperature of 2-8 degrees Celsius, it should not be exposed to direct sunlight or frozen.
IGF1 LR3 at the recommended dose, MGF PEG 200-300 mcg in the target muscles after training (3 times a week), ACE-031 100 mcg per day.
Side effects of this drug may include: pain and redness at the injection site, a decrease in blood sugar, tunnel syndrome, accelerated growth of existing tumors (it is necessary to be diagnosed before using the drug).
|The purpose of the medication||Peptides|